 |
|
| | A substance being studied in the treatment of some types of cancer. CI-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib and canertinib dihydrochloride. |
| Previous Definitions: | chronic obstructive pulmonary disease, chronic pain, chronic phase, chronic phase chronic myelogenous leukemia, CHS 828 | | Next Definitions: | CI-958, CI-980, CI-994, cidofovir, cilengitide |
|
|
